TACKLING ANTI-MICROBIAL RESISTANCE AND NEW INCENTIVES FOR DRUG DISCOVERY
British Embassy Berlin
The barriers to investment in innovative drug development are one of the most urgent challenges facing the global effort to tackle AMR.
The British Embassy Berlin and Department for International Trade are delighted to invite you to join us at the Anglo-German Club in Hamburg, to exchange ideas about how national, regional and ultimately global market incentive solutions can be used to support the discovery of new antibiotics.
The UK launched a pioneering value-based subscription style model for antibiotics earlier this year. We are pleased to be joined by NICE, who will be able to offer more detail on the NHS trial. We will also be joined by speakers from NIHR, the largest national clinical research funder in Europe and the UK government’s innovation agency Innovate UK.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.